Meet the Little-Known Chinese CAR-T Biotech Up More Than 500% Since June 2017
The company reported positive results from early studies in 35 patients with a type of blood cancer last year. Source: BioSpace
The company reported positive results from early studies in 35 patients with a type of blood cancer last year. Source: BioSpace
The company is addressing the FDA’s complaints regarding manufacturing practices, which stem from a routine inspection in January, Source: BioSpace
ImmunoGen gave a pipeline progress report and 2017 operating results last week. Source: BioSpace
Astellas will gain Universal Cells' proprietary Universal Donor Cell technology to create cell therapy products that do not require HLA matching. Source: BioSpace
The FDA approved Vertex's Symdeko for cystic fibrosis in patients ages 12 and older with two copies of the F508del mutation. Source: BioSpace
The acquisition will strengthen Charles River's position as a global early-stage CRO, expanding its client base and service portfolio. Source: BioSpace
Bob Hugin announced his campaign on Monday in an email. Source: BioSpace
The Branford, CT-based company was founded in 2017 and plans to list on the Nasdaq under the symbol BTAI. Source: BioSpace
That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace
AmerisourceBergen is one of the biggest drug distributors in the U.S. Source: BioSpace